PNC Financial Services Group
ADVM

PNC Financial Services Group’s Adverum Biotechnologies ADVM Stock Holding History

PNC Financial Services Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5
Closed – – 3952
2016
Q2 		$0 Hold
5
– – ﹤0.01% 4489
2016
Q1 		$0 Hold
5
– – ﹤0.01% 4495
2015
Q4 		$0 Hold
5
– – ﹤0.01% 4453
2015
Q3 		$0 Buy
5
+3
+150% +$383 ﹤0.01% 4605
2015
Q2 		$0 Buy
2
+1
+100% +$337 ﹤0.01% 4677
2015
Q1 		$0 Hold
1
– – ﹤0.01% 4686
2014
Q4 		$1K Buy
+1
New +$385 ﹤0.01% 3953

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PNC Financial Services Group's ADVM Position: Q3 2016 in Review

PNC Financial Services Group sold out of Adverum Biotechnologies (ADVM) in Q3 2016, closing a stake of 5 shares.

PNC Financial Services Group first reported a position in ADVM in Q4 2014 and held it in 7 quarters. The position peaked at $1K in Q4 2014. 76 funds tracked by Wall St. Rank hold ADVM as of Q3 2016.

  • PNC Financial Services Group reported no remaining Adverum Biotechnologies position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Adverum Biotechnologies shares in Q3 2016.
  • PNC Financial Services Group first reported a position in Adverum Biotechnologies in Q4 2014 and held it in 7 quarters.
  • PNC Financial Services Group's Adverum Biotechnologies position peaked at $1K in Q4 2014.
  • 76 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.